NCT04090034 2026-03-20
PRRT
Methodist Health System
Recruiting
Clinical Trials
16 trialsNCT04727723 2026-03-20
REAL-LU
Novartis
Active not recruiting
NCT06356467 2026-01-15
FARINET
IRCCS San Raffaele
Recruiting
NCT07302100 2025-12-24
DENUTNE
University Hospital, Strasbourg, France
Recruiting
NCT05064150 2025-12-18
NET-PRO
University of Iowa
Active not recruiting
NCT05196087 2025-07-02
NIP IT!
University Health Network, Toronto
Recruiting
NCT04986085 2025-03-28
NUTRIGETNE
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT06253897 2024-12-24
BackSOM
Ipsen
Completed
NCT06402695 2024-05-07
ETNA-FPG
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT06155318 2023-12-20
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
IRCCS San Raffaele
Recruiting
NCT05448157 2023-09-22
RGS-GEP-NET
European Institute of Oncology
Unknown
NCT01423734 2023-01-23
The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
Memorial Sloan Kettering Cancer Center
Completed
NCT04949282 2022-12-23
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
Recruiting
NCT02948946 2021-08-04
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT03863106 2019-03-05
LyREMeNet
Hospices Civils de Lyon
Unknown
NCT03017690 2018-12-21
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Ipsen
Completed